Toxicity of BEP chemotherapy in germ cell tumors: focus on immune-mediated bleomycin pulmonary toxicity in comparison with EP and VIP regimens
All authors: Olah P, Celec P, Vlkova B, Rejlekova K. T.
Frontiers in Immunology. 2026 Aug 3;17:1861834. doi: 10.3389/fimmu.2026.1861834.
PMID: 42609598; PMCID: PMC13478953.


